Population pharmacokinetics of gentamicin in premature newborns

B. Garcia

doi:10.1093/jac/dkl244

Population pharmacokinetics of gentamicin in premature newborns

Journal of Antimicrobial Chemotherapy ◽

10.1093/jac/dkl244 ◽

2006 ◽

Vol 58 (2) ◽

pp. 372-379 ◽

Cited By ~ 34

Author(s):

B. Garcia

Keyword(s):

Population Pharmacokinetics ◽

Premature Newborns

Download Full-text

Population Pharmacokinetics of Ceftizoxime in Premature Newborns

Developmental Pharmacology and Therapeutics ◽

10.1159/000457554 ◽

1993 ◽

Vol 20 (3-4) ◽

pp. 135-143 ◽

Cited By ~ 3

Author(s):

P. Karna ◽

C. Lee ◽

A. Kumar ◽

J. Dyke ◽

W. M. Gooch III

Keyword(s):

Population Pharmacokinetics ◽

Premature Newborns

Download Full-text

BENEFITS OF AN ADVANCED SURGICAL TREATMENT STRATEGY IN PREMATURE NEWBORNS WITH ACUTE SURGICAL PATHOLOGY WITH THE THREAT OF INTESTINAL PERFORATION

PEDIATRIA Journal named after G N SPERANSKY ◽

10.24110/0031-403x-2020-99-1-127-132 ◽

2020 ◽

Vol 99 (1) ◽

pp. 127-132

Author(s):

I.N. Prisukha ◽

◽

L.D. Belotserkovtseva ◽

M.A. Akselrov ◽

◽

...

Keyword(s):

Surgical Treatment ◽

Treatment Strategy ◽

Intestinal Perforation ◽

Surgical Pathology ◽

Premature Newborns

Download Full-text

Comparative effect of equal dose of continuous veno-venous haemofiltration and continuous veno-venous haemodiafiltration on ciprofloxacin population pharmacokinetics in septic patients

10.26226/morressier.56d6be79d462b80296c97c3b ◽

2016 ◽

Author(s):

Jason Roberts

Keyword(s):

Population Pharmacokinetics ◽

Comparative Effect ◽

Equal Dose

Download Full-text

Population Pharmacokinetics of Lenalidomide in Healthy vs Patients

10.26226/morressier.57d6b2bbd462b8028d88ef44 ◽

2016 ◽

Author(s):

Jamie Connarn

Keyword(s):

Population Pharmacokinetics

Download Full-text

Population pharmacokinetics and dosing simulations of ceftazidime in critically ill patients receiving sustained low-efficiency dialysis

10.26226/morressier.57ffb53fd462b8028d890cae ◽

2016 ◽

Author(s):

Christina König

Keyword(s):

Population Pharmacokinetics ◽

Critically Ill ◽

Critically Ill Patients ◽

Low Efficiency

Download Full-text

Population Pharmacokinetics of Opicinumab (Anti-LINGO-1) Guides The Phase IIb Dose Selection

10.26226/morressier.59a3edabd462b8028d895395 ◽

2017 ◽

Author(s):

Liang-Hui Chu

Keyword(s):

Population Pharmacokinetics ◽

Dose Selection

Download Full-text

Orphan designation: Caffeine citrate, Treatment of primary apnoea of premature newborns

Case Medical Research ◽

10.31525/cmr-176ac98 ◽

2019 ◽

Author(s):

Keyword(s):

Premature Newborns ◽

Orphan Designation ◽

Caffeine Citrate

Download Full-text

Faculty Opinions recommendation of Population pharmacokinetics of artesunate and dihydroartemisinin following intra-rectal dosing of artesunate in malaria patients.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1053997.505957 ◽

2006 ◽

Author(s):

Arjen M Dondorp

Keyword(s):

Population Pharmacokinetics

Download Full-text

Faculty Opinions recommendation of Population pharmacokinetics and pharmacodynamics of continuous versus short-term infusion of imipenem-cilastatin in critically ill patients in a randomized, controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1099302.555530 ◽

2008 ◽

Author(s):

Mathias Pletz

Keyword(s):

Randomized Controlled Trial ◽

Population Pharmacokinetics ◽

Critically Ill ◽

Critically Ill Patients ◽

Controlled Trial ◽

Pharmacokinetics And Pharmacodynamics ◽

Short Term ◽

Population Pharmacokinetics And Pharmacodynamics ◽

Randomized Controlled

Download Full-text

Faculty Opinions recommendation of Challenging recommended oral and intravenous voriconazole doses for improved efficacy and safety: population pharmacokinetics-based analysis of adult patients with invasive fungal infections.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.716397814.793455523 ◽

2012 ◽

Author(s):

Marcio Nucci

Keyword(s):

Population Pharmacokinetics ◽

Fungal Infections ◽

Invasive Fungal Infections ◽

Adult Patients ◽

Efficacy And Safety ◽

Safety Population

Download Full-text